Clinical trial
Comparative Cycle Control Europe
NCT00185367 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185367 |
|---|---|
| Title | Comparative Cycle Control Europe |
| Official title | A Multi-center, Double-blind, Double-dummy, Controlled, Randomized Study to Evaluate Cycle Control and Safety of a Four Phasic Oral Contraceptive (SH T00658ID) in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D 593 B) in Healthy Female Volunteers Aged Between… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | EV/DNG (Qlaira, BAY86-5027, SH T00658K), SH D 593 B (Miranova) |
| Enrollment | 798 |
| Start date | Mar 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 15, 2011 |
| Countries | Czechia, France, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: